Glaucoma is a group of eye conditions that damage the optic nerve, most commonly due to increased pressure within the eye. Over time, this pressure can lead to progressive vision loss and may result in permanent blindness if not properly managed. For individuals whose symptoms remain difficult to manage with conventional treatments, medical cannabis is increasingly being explored as a potential option that may help influence intraocular pressure and support eye comfort. LeafEase offers carefully developed medical cannabis solutions designed to support individuals seeking a balanced and regulated approach to managing glaucoma.
Of people over the age of 40 in the UK have glaucoma.
Of people over the age of 75 in the UK are affected by glaucoma.
Of blindness in the UK is caused by glaucoma.
700,000 people in the UK are estimated to be living with glaucoma.
If these symptoms sound familiar and continue despite conventional treatments, you can quickly check whether you may be eligible for medical cannabis treatment through our simple online assessment.
The treatment pathway for glaucoma usually begins with a comprehensive eye examination where ophthalmologists measure intraocular pressure and assess the health of the optic nerve. Conventional management commonly includes prescription eye drops designed to lower eye pressure, laser therapy, or surgical procedures that improve fluid drainage from the eye. Regular monitoring is essential to prevent disease progression and protect vision. For individuals whose symptoms remain difficult to manage despite these approaches, medical cannabis may also be explored under specialist supervision as an alternative option for symptom relief, with LeafEase providing carefully formulated medical cannabis solutions to support patients seeking additional management options.
Glaucoma most often develops when fluid within the eye does not drain properly, leading to increased pressure that gradually damages the optic nerve.
These factors may increase the risk of optic nerve damage and progressive vision loss over time.
Find out if you may be eligible for Glaucoma medical cannabis treatment here.
Medical cannabis may influence glaucoma symptoms through its interaction with the body’s endocannabinoid system, which plays a role in regulating various physiological processes including ocular pressure and neurological signalling. Cannabinoids such as CBD and THC may affect mechanisms that influence intraocular pressure and eye comfort. Some individuals also report improvements in sleep and overall wellbeing when symptoms are better managed. When prescribed under specialist supervision, medical cannabis may be considered as an alternative or complementary option for individuals whose glaucoma symptoms remain difficult to manage with conventional treatments.
Reference: https://pubmed.ncbi.nlm.nih.gov/6306517/
Reference: https://pubmed.ncbi.nlm.nih.gov/19104679/
At LeafEase, treatment is delivered under specialist supervision to ensure every patient is carefully assessed and supported throughout their care. Our personalised approach helps you explore medical cannabis as a regulated, clinically guided option for managing glaucoma symptoms.
Medical cannabis may help manage glaucoma symptoms, but some individuals may experience side effects depending on dosage, formulation, and personal response.
Most side effects are typically mild, temporary, and carefully monitored to ensure treatment remains safe and well tolerated.
Find out whether medical cannabis may be a suitable treatment option for Glaucoma
Simply submit your questions, and we’ll do our best to address them promptly and thoroughly. Your health is our priority, and we’re here to support you every step of the way.
Specialist clinicians typically review a patient’s ophthalmic history, current glaucoma treatments, and overall health before determining whether medical cannabis could be considered as part of a broader management plan.
In the UK, cannabis-based medicinal products are prescribed by specialist doctors who conduct a detailed clinical assessment, review previous treatments, and determine whether medical cannabis may be suitable under regulated guidelines.
Dosage is usually individualised by a specialist clinician who considers the patient’s symptoms, treatment history, and response to therapy while gradually adjusting the formulation where necessary.
Doctors may evaluate factors such as symptom severity, treatment history, potential medication interactions, and overall eye health before recommending cannabis-based therapy.
Specialist clinicians may prescribe regulated products such as oils or capsules depending on the patient’s clinical needs and the treatment plan designed during consultation.
Patients receiving cannabis-based treatment are typically monitored through follow-up consultations where clinicians review symptom changes, assess tolerance, and adjust therapy if required.
Specialist clinicians may consider medical cannabis alongside other treatments and supportive strategies to help manage symptoms while ensuring regular ophthalmological monitoring continues.
